We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Supernus Pharmaceuticals Closes two Transactions to Raise $42 Million

News   Jan 09, 2012

 
Supernus Pharmaceuticals Closes two Transactions to Raise $42 Million
 
 
Advertisement
 

RELATED ARTICLES

Phase 3 Clinical Trial of Belimumab for Lupus Nephritis Reports Positive Results

News

Results from the largest Phase 3 lupus nephritis clinical trial ever conducted were announced, September 16. The study, found positive results of the efficacy and safety of the drug belimumab in patients with active lupus nephritis, a condition that causes inflammation in the kidneys of patients with systemic lupus erythematosus.

READ MORE

Biologic Therapy for Psoriasis May Also Have Applications in Heart Disease

News

Patients with psoriasis treated with biologic therapy, which are protein-based infusions to suppress inflammation, had a significant reduction in high-risk plaque in heart arteries, over one-year, according to new research.

READ MORE

Using Soy-Based Compounds To Improve Bone Cancer Treatment

News

Researchers have demonstrated that the slow release of soy-based chemical compounds from a 3D-printed bone-like scaffold led to a reduction in bone cancer cells, while supporting healthy cells and reducing harmful inflammation.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE